Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients (PED-DEX)
Primary Purpose
Otitis Media
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
dexmedetomidine
saline
Sponsored by
About this trial
This is an interventional prevention trial for Otitis Media focused on measuring dexmedetomidine, pressure equalization tubes in the ear, myringotomy, sevoflurane
Eligibility Criteria
Inclusion Criteria:
- ASA class 1 or 2 (healthy patient or acute illness)
- Parental willingness to participate
- Candidate for pressure-equalization tubes (PET) as determined by the ENT department
Exclusion Criteria:
- ASA class 3 or 4 (chronic illness or life-threatening illness)
- Parental refusal to participate
- Significant liver disease by history
- Allergy to dexmedetomidine or midazolam
- Nasal deformity
- Fever in the three days prior to surgery
- Nausea or vomiting
- History of hypertension
- History of cardiac dysfunction/disorder
- Diabetes mellitus
Sites / Locations
- Ochsner Clinic Foundation
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
saline
dexmedetomidine
Arm Description
intranasal saline will be given 30 minutes prior to surgery
2 mcg/kg dexmedetomidine will be given intranasally 30 minutes prior to surgery
Outcomes
Primary Outcome Measures
To evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium in general sevoflurane anesthesia.
Secondary Outcome Measures
Evaluate post-operative pain, emesis, and time to release from recovery.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00778063
Brief Title
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Acronym
PED-DEX
Official Title
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Terminated
Why Stopped
Difficulty enrolling patients
Study Start Date
September 2008 (Actual)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ochsner Health System
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.
Detailed Description
Emergence delirium has been described as a dissociated state of consciousness in which the child is irritable, uncompromising, uncooperative, incoherent, inconsolably crying, moaning, kicking or thrashing. The children can run the gambit from restlessness and incoherence to combative and psychotic. The incidence of emergence agitation or delirium is 80% after a procedure with sevoflurane-induced anesthesia.
Dexmedetomidine has been shown to have sedative and analgesic effects. In the pediatric population, it has been shown to provide sedation for radiographic procedures. Intravenously, it is has been shown to decrease emergence delirium following sevoflurane based anesthesia. The ability to administer a medication intranasally might solve the problem of emergence delirium and emergence agitation posed by the young patients undergoing myringotomy and tube placement.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media
Keywords
dexmedetomidine, pressure equalization tubes in the ear, myringotomy, sevoflurane
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
saline
Arm Type
Placebo Comparator
Arm Description
intranasal saline will be given 30 minutes prior to surgery
Arm Title
dexmedetomidine
Arm Type
Experimental
Arm Description
2 mcg/kg dexmedetomidine will be given intranasally 30 minutes prior to surgery
Intervention Type
Drug
Intervention Name(s)
dexmedetomidine
Other Intervention Name(s)
Precedex
Intervention Description
2 mcg/kg intranasally 30 minutes prior to surgery
Intervention Type
Drug
Intervention Name(s)
saline
Intervention Description
a volume of intranasal saline, calculated based on body weight, will be given 30 minutes prior to surgery
Primary Outcome Measure Information:
Title
To evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium in general sevoflurane anesthesia.
Time Frame
2 hours post-surgery
Secondary Outcome Measure Information:
Title
Evaluate post-operative pain, emesis, and time to release from recovery.
Time Frame
2 hours post-surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
ASA class 1 or 2 (healthy patient or acute illness)
Parental willingness to participate
Candidate for pressure-equalization tubes (PET) as determined by the ENT department
Exclusion Criteria:
ASA class 3 or 4 (chronic illness or life-threatening illness)
Parental refusal to participate
Significant liver disease by history
Allergy to dexmedetomidine or midazolam
Nasal deformity
Fever in the three days prior to surgery
Nausea or vomiting
History of hypertension
History of cardiac dysfunction/disorder
Diabetes mellitus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Usha Ramadhyani, MD
Organizational Affiliation
Ochsner Health System
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dominic S Carollo, MD
Organizational Affiliation
Ochsner Health System
Official's Role
Study Director
Facility Information:
Facility Name
Ochsner Clinic Foundation
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70121
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
2007046
Citation
Olympio MA. Postanesthetic delirium: historical perspectives. J Clin Anesth. 1991 Jan-Feb;3(1):60-3. doi: 10.1016/0952-8180(91)90209-6.
Results Reference
background
PubMed Identifier
17179249
Citation
Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007 Jan;104(1):84-91. doi: 10.1213/01.ane.0000250914.91881.a8.
Results Reference
result
PubMed Identifier
10886700
Citation
Cravero J, Surgenor S, Whalen K. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane. Paediatr Anaesth. 2000;10(4):419-24. doi: 10.1046/j.1460-9592.2000.00560.x.
Results Reference
result
PubMed Identifier
16790626
Citation
Mason KP, Zgleszewski SE, Dearden JL, Dumont RS, Pirich MA, Stark CD, D'Angelo P, Macpherson S, Fontaine PJ, Connor L, Zurakowski D. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg. 2006 Jul;103(1):57-62, table of contents. doi: 10.1213/01.ane.0000216293.16613.15.
Results Reference
result
PubMed Identifier
16324031
Citation
Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth. 2005 Dec;15(12):1098-104. doi: 10.1111/j.1460-9592.2005.01660.x.
Results Reference
result
PubMed Identifier
17646493
Citation
Yuen VM, Irwin MG, Hui TW, Yuen MK, Lee LH. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg. 2007 Aug;105(2):374-80. doi: 10.1213/01.ane.0000269488.06546.7c.
Results Reference
result
PubMed Identifier
18499600
Citation
Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg. 2008 Jun;106(6):1715-21. doi: 10.1213/ane.0b013e31816c8929.
Results Reference
result
PubMed Identifier
14742362
Citation
Weldon BC, Bell M, Craddock T. The effect of caudal analgesia on emergence agitation in children after sevoflurane versus halothane anesthesia. Anesth Analg. 2004 Feb;98(2):321-326. doi: 10.1213/01.ANE.0000096004.96603.08.
Results Reference
result
PubMed Identifier
16613928
Citation
Alhashemi JA, Daghistani MF. Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children. Br J Anaesth. 2006 Jun;96(6):790-5. doi: 10.1093/bja/ael084. Epub 2006 Apr 13.
Results Reference
result
PubMed Identifier
1616162
Citation
Weldon BC, Watcha MF, White PF. Oral midazolam in children: effect of time and adjunctive therapy. Anesth Analg. 1992 Jul;75(1):51-5. doi: 10.1213/00000539-199207000-00010.
Results Reference
result
PubMed Identifier
16101707
Citation
Guler G, Akin A, Tosun Z, Ors S, Esmaoglu A, Boyaci A. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Paediatr Anaesth. 2005 Sep;15(9):762-6. doi: 10.1111/j.1460-9592.2004.01541.x.
Results Reference
result
PubMed Identifier
1394754
Citation
Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth. 1992 Sep;39(7):665-9. doi: 10.1007/BF03008227.
Results Reference
result
Learn more about this trial
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
We'll reach out to this number within 24 hrs